首页> Cancers> A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch<sup>®®</sup> NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.

A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch<sup>®®</sup> NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.

导出 OA

翻译打印收藏纠错

第一作者： Ewan,Hunter

第一单位： Oxford BioDynamics Plc., Oxford OX4 2WB, UK.

作者： Ewan,Hunter ^[1] ; Heba,Alshaker ^[2] ; Cicely,Weston ^[1] ; Mutaz,Issa ^[1] ; Shekinah,Bautista ^[1] ; Abel,Gebregzabhar ^[1] ; Anya,Virdi ^[1] ; Ann,Dring ^[1] ; Ryan,Powell ^[1] ; Jayne,Green ^[1] ; Roshan,Lal ^[3] ; Vamsi,Velchuru ^[3] ; Kamal,Aryal ^[3] ; Muhammad Radzi,Bin Abu Hassan ^[4] ; Goh Tiong,Meng ^[5] ; Janisha Suriakant,Patel ^[6] ; Shameera Pharveen,Mohamed Gani ^[6] ; Chun Ren,Lim ^[6] ; Thomas,Guiel ^[7] ; Alexandre,Akoulitchev ^[1] ; Dmitri,Pchejetski ^[2]

作者单位： Oxford BioDynamics Plc., Oxford OX4 2WB, UK. ^[1] Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK. ^[2] James Paget University Hospitals NHS Trust, Great Yarmouth NR31 6LA, UK. ^[3] Clinical Research Center, Hospital Sultanah Bahiyah, Jalan Langgar, Alor Setar 05460, Malaysia. ^[4] Island Hospital Penang, Jalan Macalister, George Town 10450, Malaysia. ^[5] Penang Reference Laboratory, Oxford BioDynamics Plc., Jalan Tanjung Tokong, George Town 10470, Malaysia. ^[6] Oxford BioDynamics Inc., Frederick, MD 21703, USA. ^[7]

关键词 3D-genomic profiling blood-based biomarkers cancer diagnosis chromosome conformations colonic polyp colorectal cancer epigenetics

DOI 10.3390/cancers17030521

PMID 39941889

发布时间 2025-02-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交